ANZU SPECIAL(ANZU) - 2025 Q4 - Annual Results

Exhibit 99.1 Envoy Medical Reports Full Year 2025 Financial Results Received FDA approval to expand fully implanted Acclaim® Cochlear Implant Pivotal Clinical Trial to final stage Strengthened balance sheet by extinguishing $32 million in debt Subsequent to year-end, closed on transformational capital raise led by established institutional healthcare investors and completed enrollment of Pivotal Clinical Trial for first-of-its-kind fully implanted cochlear implant White Bear Lake, Minnesota – March 23, 2026 ...